H.C. Wainwright raised the firm’s price target on Argenx (ARGX) to $774 from $720 and keeps a Buy rating on the shares. The company reported a “jaw-dropping” Q2, the analyst tells investors in a research note. The firm cites Vyvgart’s “robust” sales performance for the target increase.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx Reports Strong Growth and Strategic Advances
- Argenx Earnings Call: Strong Growth and Innovation
- Argenx’s Vyvgart Sales Surpass Expectations, Driving Buy Rating with Promising Pipeline and Market Expansion
- Argenx price target raised to $756 from $741 at Wells Fargo
- Argenx SE’s Strong Q2 Performance and Positive Outlook Reinforce Buy Rating